HK Stock MarketDetailed Quotes

09995 REMEGEN

Watchlist
  • 15.940
  • -0.880-5.23%
Market Closed Dec 13 16:08 CST
8.68BMarket Cap-5.04P/E (TTM)

REMEGEN Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Turnover
57.10%1.21B
76.50%739.66M
96.41%330.43M
40.16%1.08B
35.08%769.47M
20.15%419.07M
12.06%168.24M
-46.08%767.78M
397.47%569.64M
1,094.78%348.78M
Operating income
57.10%1.21B
76.50%739.66M
96.41%330.43M
40.16%1.08B
35.08%769.47M
20.15%419.07M
12.06%168.24M
-46.08%767.78M
397.47%569.64M
1,094.78%348.78M
Cost of sales
----
-64.89%-169.27M
----
6.22%-253.14M
----
38.72%-102.66M
----
-301.92%-269.94M
----
-3,510.02%-167.51M
Operating expenses
-37.65%-244.74M
-64.89%-169.27M
-196.17%-74.36M
6.22%-253.14M
20.47%-177.8M
38.72%-102.66M
74.25%-25.11M
-301.92%-269.94M
-2,079.96%-223.57M
-3,510.02%-167.51M
Gross profit
62.95%964.13M
80.26%570.39M
78.91%256.08M
65.31%822.99M
70.97%591.67M
74.55%316.42M
171.98%143.13M
-63.31%497.84M
231.95%346.06M
638.33%181.27M
Selling expenses
-15.36%-622.7M
-11.28%-389.67M
-18.81%-187.5M
-75.90%-775.19M
-94.41%-539.79M
-133.51%-350.17M
-95.36%-157.82M
-67.59%-440.7M
-115.68%-277.66M
-146.27%-149.96M
Administrative expenses
3.39%-234.62M
7.94%-155.22M
5.70%-74.26M
-15.09%-313.67M
-51.17%-242.87M
-57.70%-168.61M
-60.52%-78.75M
-23.97%-272.54M
-0.86%-160.66M
-8.42%-106.92M
Research and development expenses
-34.43%-1.15B
-49.18%-806.23M
-32.62%-331.18M
-33.01%-1.31B
-29.50%-857.98M
-20.19%-540.45M
-14.46%-249.72M
-38.13%-982.08M
-26.29%-662.54M
-37.68%-449.67M
Profit from asset sales
--88.36K
----
----
----
----
----
----
----
-3.02%15.5K
----
Revaluation surplus
-86.10%718.29K
----
-101.81%-49.46K
----
-55.15%5.17M
----
--2.73M
----
--11.53M
----
-Changes in the fair value of other assets
-86.10%718.29K
----
-101.81%-49.46K
----
-55.15%5.17M
----
--2.73M
----
--11.53M
----
Impairment and provision
-5.77%-15.78M
7.30%-3.81M
-346.42%-4.66M
-1.33%-11.28M
-63.53%-14.92M
26.58%-4.11M
229.03%1.89M
-3,153.80%-11.13M
-1,814.98%-9.12M
-2,386.67%-5.6M
-Other impairment is provision
-5.77%-15.78M
7.30%-3.81M
-346.42%-4.66M
-1.33%-11.28M
-63.53%-14.92M
26.58%-4.11M
229.03%1.89M
-3,153.80%-11.13M
-1,814.98%-9.12M
-2,386.67%-5.6M
Special items of operating profit
87.59%66.48M
-27.46%35.95M
2.19%11.78M
-55.96%95.35M
32.59%35.44M
12.83%49.56M
55.95%11.53M
82.02%216.54M
43.26%26.73M
117.26%43.92M
Operating profit
2.21%-1.01B
-7.35%-748.59M
-1.58%-334.24M
-50.00%-1.49B
-40.94%-1.03B
-43.21%-697.37M
-13.06%-329.03M
-452.32%-992.07M
-5.41%-730.19M
-10.28%-486.95M
Financing cost
-1,239.27%-49.5M
-431.38%-31.87M
-256.14%-10.71M
-241.73%-23.09M
-91.90%4.34M
-175.72%-6M
-17.79%6.86M
-26.94%-6.76M
128.81%53.61M
11.94%-2.18M
Share of profits of associates
----
----
----
---45K
----
----
----
----
----
----
Special items of earning before tax
-169.36%-15.56M
----
-147.00%-3.97M
----
50.34%-5.78M
----
61.33%-1.61M
----
38.68%-11.64M
----
Earning before tax
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
After-tax profit from continuing operations
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
Earning after tax
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
Profit attributable to shareholders
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
Basic earnings per share
-4.19%-1.99
-11.54%-1.45
-8.33%-0.65
-48.94%-2.8
-44.70%-1.91
-35.42%-1.3
-1.69%-0.6
-429.82%-1.88
6.38%-1.32
-5.49%-0.96
Diluted earnings per share
-4.19%-1.99
-11.54%-1.45
-8.33%-0.65
-48.94%-2.8
-44.70%-1.91
-35.42%-1.3
-1.69%-0.6
-429.82%-1.88
6.38%-1.32
-5.49%-0.96
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Ernst & Young
--
--
--
Ernst & Young
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Turnover 57.10%1.21B76.50%739.66M96.41%330.43M40.16%1.08B35.08%769.47M20.15%419.07M12.06%168.24M-46.08%767.78M397.47%569.64M1,094.78%348.78M
Operating income 57.10%1.21B76.50%739.66M96.41%330.43M40.16%1.08B35.08%769.47M20.15%419.07M12.06%168.24M-46.08%767.78M397.47%569.64M1,094.78%348.78M
Cost of sales -----64.89%-169.27M----6.22%-253.14M----38.72%-102.66M-----301.92%-269.94M-----3,510.02%-167.51M
Operating expenses -37.65%-244.74M-64.89%-169.27M-196.17%-74.36M6.22%-253.14M20.47%-177.8M38.72%-102.66M74.25%-25.11M-301.92%-269.94M-2,079.96%-223.57M-3,510.02%-167.51M
Gross profit 62.95%964.13M80.26%570.39M78.91%256.08M65.31%822.99M70.97%591.67M74.55%316.42M171.98%143.13M-63.31%497.84M231.95%346.06M638.33%181.27M
Selling expenses -15.36%-622.7M-11.28%-389.67M-18.81%-187.5M-75.90%-775.19M-94.41%-539.79M-133.51%-350.17M-95.36%-157.82M-67.59%-440.7M-115.68%-277.66M-146.27%-149.96M
Administrative expenses 3.39%-234.62M7.94%-155.22M5.70%-74.26M-15.09%-313.67M-51.17%-242.87M-57.70%-168.61M-60.52%-78.75M-23.97%-272.54M-0.86%-160.66M-8.42%-106.92M
Research and development expenses -34.43%-1.15B-49.18%-806.23M-32.62%-331.18M-33.01%-1.31B-29.50%-857.98M-20.19%-540.45M-14.46%-249.72M-38.13%-982.08M-26.29%-662.54M-37.68%-449.67M
Profit from asset sales --88.36K-----------------------------3.02%15.5K----
Revaluation surplus -86.10%718.29K-----101.81%-49.46K-----55.15%5.17M------2.73M------11.53M----
-Changes in the fair value of other assets -86.10%718.29K-----101.81%-49.46K-----55.15%5.17M------2.73M------11.53M----
Impairment and provision -5.77%-15.78M7.30%-3.81M-346.42%-4.66M-1.33%-11.28M-63.53%-14.92M26.58%-4.11M229.03%1.89M-3,153.80%-11.13M-1,814.98%-9.12M-2,386.67%-5.6M
-Other impairment is provision -5.77%-15.78M7.30%-3.81M-346.42%-4.66M-1.33%-11.28M-63.53%-14.92M26.58%-4.11M229.03%1.89M-3,153.80%-11.13M-1,814.98%-9.12M-2,386.67%-5.6M
Special items of operating profit 87.59%66.48M-27.46%35.95M2.19%11.78M-55.96%95.35M32.59%35.44M12.83%49.56M55.95%11.53M82.02%216.54M43.26%26.73M117.26%43.92M
Operating profit 2.21%-1.01B-7.35%-748.59M-1.58%-334.24M-50.00%-1.49B-40.94%-1.03B-43.21%-697.37M-13.06%-329.03M-452.32%-992.07M-5.41%-730.19M-10.28%-486.95M
Financing cost -1,239.27%-49.5M-431.38%-31.87M-256.14%-10.71M-241.73%-23.09M-91.90%4.34M-175.72%-6M-17.79%6.86M-26.94%-6.76M128.81%53.61M11.94%-2.18M
Share of profits of associates ---------------45K------------------------
Special items of earning before tax -169.36%-15.56M-----147.00%-3.97M----50.34%-5.78M----61.33%-1.61M----38.68%-11.64M----
Earning before tax -3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M
After-tax profit from continuing operations -3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M
Earning after tax -3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M
Profit attributable to shareholders -3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M
Basic earnings per share -4.19%-1.99-11.54%-1.45-8.33%-0.65-48.94%-2.8-44.70%-1.91-35.42%-1.3-1.69%-0.6-429.82%-1.886.38%-1.32-5.49%-0.96
Diluted earnings per share -4.19%-1.99-11.54%-1.45-8.33%-0.65-48.94%-2.8-44.70%-1.91-35.42%-1.3-1.69%-0.6-429.82%-1.886.38%-1.32-5.49%-0.96
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Ernst & Young------Ernst & Young----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data